Patent · US Expired

Recombinant baculovirus and use thereof in the production of monoclonal antibodies

US6852507B1 · kind B1 · utility

8Cited by
2References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 21, 1997
Grant dateFeb 8, 2005
Priority date
Expiry dateNov 21, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/14143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Recombinant baculovirus used as an expression vector in the production of immunoglobulins with an insect cell. The invention is characterized by a first expression cassette comprising a first sequence coding for at least one portion of an immunoglobulin heavy chain, wherein the sequence is transcriptionally controlled by a first baculovirus promoter, and a second expression cassette comprising a second sequence coding for at least one portion of an immunoglobulin light chain, said second sequence being transcriptionally controlled by a second baculovirus promoter. The first and second promoters are two different promoters or derivatives of different promoters, the first and second promoters residing at different loci.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.